• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突触前 GLP-1 受体增强了谷氨酸和 GABA 在小鼠大脑皮层和海马中的去极化诱发释放。

Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus.

机构信息

Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genova, Italy.

Department of Experimental Medicine, Section of Biochemistry and Italian Institute of Biostructures and Biosystems, University of Genova, Italy.

出版信息

Biofactors. 2018 Mar;44(2):148-157. doi: 10.1002/biof.1406. Epub 2017 Dec 19.

DOI:10.1002/biof.1406
PMID:29265673
Abstract

Glucagon-like peptide-1 receptors (GLP-1Rs) have been shown to mediate cognitive-enhancing and neuroprotective effects in the central nervous system. However, little is known about their physiological roles on central neurotransmission, especially at the presynaptic level. Using purified synaptosomal preparations and immunofluorescence techniques, here we show for the first time that GLP-1Rs are localized on mouse cortical and hippocampal synaptic boutons, in particular on glutamatergic and GABAergic nerve terminals. Their activation by the selective agonist exendin-4 (1-100 nM) was able to increase the release of either [ H]d-aspartate or [ H]GABA. These effects were abolished by 10 nM of the selective GLP1-R antagonist exendin-3 (9-39) and were prevented by the selective adenylyl cyclase inhibitor 2',5'-dideoxyadenosine (10 µM), indicating the involvement of classic GLP-1Rs coupled to G protein stimulating cAMP synthesis. Our data demonstrate the existence and activity of presynaptic receptors for GLP-1 that could represent additional mechanisms by which this neurohormone exerts its effects in the CNS. © 2017 BioFactors, 44(2):148-157, 2018.

摘要

胰高血糖素样肽-1 受体 (GLP-1Rs) 已被证明在中枢神经系统中具有增强认知和神经保护作用。然而,关于它们在中枢神经传递中的生理作用,特别是在突触前水平上的作用,知之甚少。本研究使用纯化的突触小体制剂和免疫荧光技术,首次表明 GLP-1Rs 定位于小鼠皮质和海马突触小体上,特别是在谷氨酸能和 GABA 能神经末梢上。选择性激动剂 exendin-4(1-100 nM)的激活能够增加 [ H]d-天冬氨酸或 [ H]GABA 的释放。这些作用被 10 nM 的选择性 GLP1-R 拮抗剂 exendin-3(9-39)所阻断,并且被选择性腺苷酸环化酶抑制剂 2',5'-双脱氧腺苷(10 µM)所预防,表明存在经典的 GLP-1R 与 G 蛋白偶联,刺激 cAMP 的合成。我们的数据表明存在和活性的 GLP-1 突触前受体,这可能是这种神经激素在中枢神经系统中发挥作用的额外机制。

相似文献

1
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus.突触前 GLP-1 受体增强了谷氨酸和 GABA 在小鼠大脑皮层和海马中的去极化诱发释放。
Biofactors. 2018 Mar;44(2):148-157. doi: 10.1002/biof.1406. Epub 2017 Dec 19.
2
Somatostatin inhibits glutamate release from mouse cerebrocortical nerve endings through presynaptic sst2 receptors linked to the adenylyl cyclase-protein kinase A pathway.生长抑素通过与腺苷酸环化酶 - 蛋白激酶A途径相关的突触前sst2受体抑制小鼠大脑皮质神经末梢释放谷氨酸。
Neuropharmacology. 2004 Mar;46(3):388-96. doi: 10.1016/j.neuropharm.2003.09.012.
3
Inhibition of sigma-1 receptors substantially modulates GABA and glutamate transport in presynaptic nerve terminals.σ-1 受体抑制剂可显著调节突触前神经末梢 GABA 和谷氨酸的转运。
Exp Neurol. 2020 Nov;333:113434. doi: 10.1016/j.expneurol.2020.113434. Epub 2020 Aug 11.
4
Pre-synaptic histamine H3 receptors regulate glutamate, but not GABA release in rat thalamus.突触前组胺H3受体调节大鼠丘脑谷氨酸的释放,但不调节γ-氨基丁酸的释放。
Neuropharmacology. 2007 Feb;52(2):527-35. doi: 10.1016/j.neuropharm.2006.08.001. Epub 2006 Oct 5.
5
Presynaptic kainate receptor facilitation of glutamate release involves protein kinase A in the rat hippocampus.大鼠海马中,突触前海人藻酸受体对谷氨酸释放的促进作用涉及蛋白激酶A。
J Physiol. 2004 Jun 15;557(Pt 3):733-45. doi: 10.1113/jphysiol.2004.065029. Epub 2004 Apr 23.
6
Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor/β-endorphin pathway.肽类艾塞那肽和中药梓醇通过海马GLP-1受体/β-内啡肽途径介导神经保护作用。
Pharmacol Res. 2015 Dec;102:276-85. doi: 10.1016/j.phrs.2015.10.008. Epub 2015 Nov 3.
7
5-HT receptor agonist CGS12066 presynaptically inhibits glutamate release in rat hippocampus.5-HT 受体激动剂 CGS12066 对大鼠海马突触前抑制谷氨酸释放。
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Aug 30;86:122-130. doi: 10.1016/j.pnpbp.2018.05.019. Epub 2018 May 24.
8
Under stressful conditions activation of the ionotropic P2X7 receptor differentially regulates GABA and glutamate release from nerve terminals of the rat cerebral cortex.在应激条件下,离子型 P2X7 受体的激活可差异化调节大鼠大脑皮层神经末梢 GABA 和谷氨酸的释放。
Neurochem Int. 2018 Jan;112:81-95. doi: 10.1016/j.neuint.2017.11.005. Epub 2017 Nov 14.
9
Activation of gamma-aminobutyric acid GAT-1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal.小鼠脊髓谷氨酸能终末上γ-氨基丁酸GAT-1转运体的激活通过阴离子通道并经转运体翻转介导谷氨酸释放。
J Neurosci Res. 2005 May 1;80(3):424-33. doi: 10.1002/jnr.20437.
10
Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.突触前 mGlu7 受体控制小鼠海马 GABA 释放。
Neuropharmacology. 2013 Mar;66:215-24. doi: 10.1016/j.neuropharm.2012.04.020. Epub 2012 Apr 27.

引用本文的文献

1
Glucagon-like Peptide-1 receptor agonists as emerging therapeutics in bipolar disorder: a narrative review of preclinical and clinical evidence.胰高血糖素样肽-1受体激动剂作为双相情感障碍的新兴治疗方法:临床前和临床证据的叙述性综述
Mol Psychiatry. 2025 Sep 13. doi: 10.1038/s41380-025-03261-0.
2
The Connection Between the Appetite-Regulatory Peptides Ghrelin and GLP-1 and Alcohol Use Disorder.食欲调节肽胃饥饿素和胰高血糖素样肽-1与酒精使用障碍之间的联系
Adv Exp Med Biol. 2025;1477:229-241. doi: 10.1007/978-3-031-89525-8_8.
3
Beyond Diabetes: Semaglutide's Role in Modulating Mood Disorders through Neuroinflammation Pathways.
超越糖尿病:司美格鲁肽通过神经炎症途径在调节情绪障碍中的作用。
Cell Mol Neurobiol. 2025 Mar 10;45(1):22. doi: 10.1007/s10571-025-01534-4.
4
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking.一种内源性胰高血糖素样肽-1(GLP-1)回路作用于腹侧被盖区(VTA)的γ-氨基丁酸(GABA)能神经元,以调节中脑边缘多巴胺能神经元并减少可卡因觅求行为。
Sci Adv. 2025 Feb 28;11(9):eadr5051. doi: 10.1126/sciadv.adr5051. Epub 2025 Feb 26.
5
Pharmacogenomic Assessment of Glucagon-like Peptide-1 (GLP1) Agonists and the Genetic Addiction Risk Score (GARS) Related Pathways: Implications for Suicidal Ideation and Substance Use Disorder.胰高血糖素样肽-1(GLP1)激动剂的药物基因组学评估及与遗传成瘾风险评分(GARS)相关的途径:对自杀意念和物质使用障碍的影响
Curr Neuropharmacol. 2025;23(8):974-995. doi: 10.2174/011570159X349579241231080602.
6
Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial).司美格鲁肽能否减少丹麦酒精使用障碍合并肥胖患者的酒精摄入量?一项随机、双盲、安慰剂对照临床试验的试验方案(SEMACLO试验)。
BMJ Open. 2025 Jan 8;15(1):e086454. doi: 10.1136/bmjopen-2024-086454.
7
GLP-1 and its derived peptides mediate pain relief through direct TRPV1 inhibition without affecting thermoregulation.胰高血糖素样肽-1(GLP-1)及其衍生肽通过直接抑制瞬时受体电位香草酸亚型1(TRPV1)来介导疼痛缓解,而不影响体温调节。
Exp Mol Med. 2024 Nov;56(11):2449-2464. doi: 10.1038/s12276-024-01342-8. Epub 2024 Nov 1.
8
The evolving role of GLP-1 agonists in ischemic stroke prevention in diabetic patients.胰高血糖素样肽-1激动剂在糖尿病患者缺血性卒中预防中不断演变的作用。
Cardiovasc Endocrinol Metab. 2024 Aug 14;13(3):e00308. doi: 10.1097/XCE.0000000000000308. eCollection 2024 Sep.
9
Unlocking the Potential: Semaglutide's Impact on Alzheimer's and Parkinson's Disease in Animal Models.释放潜力:司美格鲁肽在动物模型中对阿尔茨海默病和帕金森病的影响
Curr Issues Mol Biol. 2024 Jun 13;46(6):5929-5949. doi: 10.3390/cimb46060354.
10
Populations of Hindbrain Glucagon-Like Peptide 1 (GLP1) Neurons That Innervate the Hypothalamic PVH, Thalamic PVT, or Limbic Forebrain BST Have Axon Collaterals That Reach All Central Regions Innervated by GLP1 Neurons.支配下丘脑 PVH、丘脑 PVT 或边缘前脑 BST 的后脑胰高血糖素样肽 1 (GLP1) 神经元的群体具有轴突侧支,可到达 GLP1 神经元支配的所有中枢区域。
J Neurosci. 2024 Jul 31;44(31):e2063232024. doi: 10.1523/JNEUROSCI.2063-23.2024.